BIMEKIZUMAB (Bimzelx®)

Clinical Indication

Moderate to severe plaque psoriasis

Comments

In line with NICE TA723

Date of classification

October 2021

Review date

October 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).